T1	Participants 56 72	major depression
T2	Participants 177 191	75 outpatients
T3	Participants 197 231	dosage of moclobemide (25 patients
T4	Participants 317 340	Imipramine (25 patients
T5	Participants 486 514	25 patients received placebo
